Impaired Development of Th2 Cells in IL-13-Deficient Mice

Slides:



Advertisements
Similar presentations
Volume 15, Issue 2, Pages (August 2001)
Advertisements

Suneet Agarwal, Anjana Rao  Immunity 
Volume 17, Issue 1, Pages 7-17 (July 2002)
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 13, Issue 5, Pages (November 2000)
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 9, Issue 4, Pages (October 1998)
Volume 31, Issue 2, Pages (August 2009)
Volume 5, Issue 3, Pages (September 1996)
Ling Lin, Jonathan D. Hron, Stanford L. Peng  Immunity 
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 5, Pages (November 1999)
Volume 5, Issue 4, Pages (October 1996)
Volume 11, Issue 4, Pages (October 1999)
Volume 20, Issue 5, Pages (May 2004)
Volume 11, Issue 6, Pages (December 1999)
Balthazar B Cazac, Jürgen Roes  Immunity 
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 5, Issue 5, Pages (November 1996)
Volume 13, Issue 3, Pages (September 2000)
Volume 24, Issue 3, Pages (March 2006)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
Impaired Th2 Subset Development in the Absence of CD4
Pax5/BSAP Maintains the Identity of B Cells in Late B Lymphopoiesis
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Genetic disruption of p38α Tyr323 phosphorylation prevents T-cell receptor–mediated p38α activation and impairs interferon-γ production by Ludmila Jirmanova,
Volume 13, Issue 4, Pages (October 2000)
Volume 17, Issue 1, Pages (July 2002)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 5, Issue 3, Pages (September 1996)
Volume 8, Issue 1, Pages (January 1998)
Volume 14, Issue 5, Pages (May 2001)
Volume 19, Issue 5, Pages (November 2003)
Volume 6, Issue 3, Pages (March 1997)
Volume 4, Issue 4, Pages (April 1996)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 84, Issue 4, Pages (February 1996)
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice  Roberta.
IgH Class Switch Recombination to IgG1 in DNA-PKcs-Deficient B Cells
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 9, Issue 5, Pages (November 1998)
Volume 16, Issue 6, Pages (June 2002)
CD40, but Not CD40L, Is Required for the Optimal Priming of T Cells and Control of Aerosol M. tuberculosis Infection  Vanja Lazarevic, Amy J Myers, Charles.
Volume 29, Issue 1, Pages (July 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 15, Issue 2, Pages (August 2001)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 31, Issue 2, Pages (August 2009)
Regulation of Expression of IL-4 Alleles
Volume 10, Issue 4, Pages (April 1999)
Volume 16, Issue 4, Pages (April 2002)
TRAF1 Is a Negative Regulator of TNF Signaling
Volume 28, Issue 5, Pages (May 2008)
Volume 36, Issue 5, Pages (May 2012)
Volume 14, Issue 1, Pages (January 2001)
Volume 15, Issue 4, Pages (October 2001)
Volume 4, Issue 2, Pages (February 1996)
Volume 24, Issue 1, Pages (January 2006)
Volume 28, Issue 1, Pages (January 2008)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Regulation of the Th2 Cytokine Locus by a Locus Control Region
Volume 4, Issue 5, Pages (May 1996)
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

Impaired Development of Th2 Cells in IL-13-Deficient Mice Grahame J McKenzie, Claire L Emson, Sarah E Bell, Shannon Anderson, Padraic Fallon, Gerard Zurawski, Richard Murray, Richard Grencis, Andrew N.J McKenzie  Immunity  Volume 9, Issue 3, Pages 423-432 (September 1998) DOI: 10.1016/S1074-7613(00)80625-1

Figure 1 Disruption of the IL-13 Gene by Gene Targeting (A) The structure of the IL-13 locus, the targeting vector, and the predicted homologous recombination event are shown. A replacement targeting vector containing 6 kb and 1.5 kb of 5′ and 3′ homology, flanking the neomycin resistance gene, was constructed. (B) Southern blot analysis of F2 tail DNA. BglII-digested DNAs were hybridized with the 3′ flanking probe (probe A). The endogenous and targeted alleles are 6.0 kb and 7.2 kb, respectively. Immunity 1998 9, 423-432DOI: (10.1016/S1074-7613(00)80625-1)

Figure 2 Cytokine Production Following In Vitro Th Cell Differentiation (A) CD4+ T cells purified from pooled spleens from three wild-type or three IL-13−/− mice were stimulated under Th1 or Th2 culture conditions (or Th2 conditions with the addition of 100 ng/ml IL-13) for 5 days, washed, and restimulated on anti-CD3 antibody coated plates for 24 hr. Supernatants were analyzed by ELISA. Data are representative of four repeat experiments. (B) Splenocytes were stimulated under Th1 or Th2 culture conditions for 5 days, washed, and restimulated on anti-CD3 antibody coated plates for 24 hr. Supernatants were analyzed by ELISA. Data are representative of five repeat experiments. Immunity 1998 9, 423-432DOI: (10.1016/S1074-7613(00)80625-1)

Figure 3 Cytokine Production in Response to Antigen Immunization or Parasite Infection (A) Mesenteric lymph node cells, isolated from schistosome egg challenged animals, were cultured with soluble egg antigen (SEA) for 5 days before supernatants were analyzed for IL-4 and IL-5 production by ELISA. Representative data from three repeat experiments with five animals per group. (B) Mesenteric lymph node cells, isolated from schistosome egg-challenged animals, were cultured using Th2 differentiation conditions. Representative data from three repeat experiments with five animals per group. (C) Mesenteric lymph node cells were prepared from uninfected animals (day 0) or animals 6 days and 10 days postinfection with N. brasiliensis. Cells were stimulated under Th2 culture conditions for 5 days, washed, and restimulated on anti-CD3 antibody coated plates for 24 hr. Supernatants were analyzed by ELISA. Data are representative of two repeat experiments consisting of cohorts of five mice at each time point. Immunity 1998 9, 423-432DOI: (10.1016/S1074-7613(00)80625-1)

Figure 4 Th2 Cytokine Production Following Removal of the Neomycin Selection Cassette Using cre-Mediated loxP Recombination (A) The structure of the IL-13 locus, the targeting vector, and the predicted homologous recombination event before and after excision of the neomycin cassette are shown (loxP sites indicated by broad arrows). (B) Southern blot analysis of ES cell genomic DNA following cre-mediated recombination. BamHI-digested DNAs were hybridized with the IL-13 cDNA probe. The endogenous allele and targeted alleles are 6.0 kb and 4.8 kb, respectively. The neomycin excised allele is 3.2 kb (+/− creed). (C) Mesenteric lymph node cells from wild-type and IL-13−/− creed were stimulated under Th2 culture conditions for 5 days, washed, and restimulated on anti-CD3 antibody-coated plates for 24 hr. Supernatants were analyzed by ELISA. Data are representative of two repeat experiments with three mice per group. Immunity 1998 9, 423-432DOI: (10.1016/S1074-7613(00)80625-1)

Figure 5 Mast Cell Cytokine Production (A) Mast cells were stimulated with PMA and ionomycin and supernatants were sampled after 24 hr. Cytokine levels were analyzed by ELISA. Representative data from three repeat experiments with cells prepared from three mice. (B) RT-PCR analysis of spleen-derived mast cells stimulated with IgE and specific antigen, PMA, and calcium ionophore A23187. Immunity 1998 9, 423-432DOI: (10.1016/S1074-7613(00)80625-1)

Figure 6 Cytokine Production Following In Vivo Administration of IL-13 (A) Mesenteric lymph node cells from wild-type animals immunized with schistosome eggs and IL-13, or denatured IL-13 (con), were cultured with soluble egg antigen for 5 days. Representative data from two repeat experiments with five animals in each group. Supernatants were assayed for cytokine concentration using ELISA. (B) Mesenteric lymph node cells, derived from N. brasiliensis–infected wild-type animals, IL-13−/− animals, or IL-13−/− animals treated with rmIL-13, were stimulated for 24 hr with Con A. Supernatants were analyzed for the presence of IL-5 and IL-4 by ELISA. Data represent triplicate cultures from five animals per group. Immunity 1998 9, 423-432DOI: (10.1016/S1074-7613(00)80625-1)

Figure 7 Serum Immunoglobulin Levels from Naive and Immunized Animals (A) Total serum concentration of immunoglobulin isotypes from naive wild-type and IL-13−/− mice. Representative data from three repeat experiments. (B) Serum IgE levels from mice immunized with ovalbumin/alum. Representative data from two repeat experiments. Closed circle, wild-type; open circle, IL-13−/−; plus, mean. (C) Serum IgE levels detected at day 10 postinfection of mice with N. brasiliensis (data represent the mean (± SD) in groups of five mice). Shaded columns are wild-type, open columns are IL-13−/−. (D) Serum ovalbumin-specific immunoglobulin isotype responses to ovalbumin/alum following immunization over a 40-day period. Cohorts of five animals were analyzed. Immunity 1998 9, 423-432DOI: (10.1016/S1074-7613(00)80625-1)